Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease
Clinical trial NCT07061938 · RECRUITING
Trial details
- NCT number
- NCT07061938
- Sponsor
- Acepodia Biotech, Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-01
- Primary completion
- 2027-01-20
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.